Holmes arriving to federal court in San Jose, California, on Nov 18, 2022. A federal judge sentenced Holmes to an 11-year prison sentence for duping investors and endangering patients while peddling a bogus blood-testing technology. — AP
SAN JOSÉ, United States: Elizabeth Holmes’s startup Theranos made her a multi-billionaire hailed as the next US tech visionary by age 30, but it all evaporated in a flash of lawsuits, ignominy and, finally, an 11-year prison sentence on Nov 18.
The rise and fall of Holmes, who in January was convicted of defrauding investors of her biotech startup, is a heavily chronicled saga that prompted a hard look at her methods but also the unseemly aspects of startup life.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
